Our PUBLISHER ALERTS Are UP over 1500%, It's VERIFIABLE $1000 would have GROWN to over $15000 in the last 6 weeks. Follow Sierra on Twitter To Get The Next PUBLISHER ALERT~~Follow Sierra on Twitter


With over 1 million visitors to our blog and sites and thousands of visitors daily Sierra World Equity Review will be giving massive MULTIPLE DAY targeted audience exposure to our NEW PUBLISHER ALERT # 13, Optex Systems Holdings (OPXS), the share price is only going to explode upwards predicts Sierra World Equity Review.

Providing special focus to speculative potential mergers, acquisitions, buyouts, and joint ventures as well as BUY or SELL ratings along with 10 day short term PRICE TARGETS! With countless accurate calls, Sierra World Equity Review is lighting up the stock market with our accurate forecasts and predictions!!
Hot Stocks For 2014 To Watch Thursday, April 24th
Top Penny Stocks OPXS, AEGY, ERBB
Hot Biotech Stocks ARIA, GALE, CHTP
Top Oil And Gas Stocks MHR,CHK, KOG
Best Gold Stocks ABX, NEM, ANV
Top Insurance Stocks MET, PRU, MFC
Hot ETF's EEM, EWJ, GDX
Best Marijuana Stocks LXRP, HEMP, ERBB

Sunday, September 9, 2012

European Medicines Agency Approval for Lorcaserin (Belviq) to come SOONER than Expected ventures Sierra World Equity Review, GREAT news for Arena Pharmaceuticals (ARNA)

Sierra World Equity Review is now predicting that approval for Arena Pharmaceuticals (ARNA) lorcaserin (Belviq) for marketing in the EU will be coming SOONER THAN EXPECTED, Sierra also believes that the application in Switzerland for marketing will ALSO be approved VERY SOON! Accurate Sierra believes that ARNA stock will soon be heading up as it rebounds from the recent terrible call by Credit Suisse. Remember you heard it here FIRST...Instant updates may come at anytime as Sierra and her team closely monitors developments.....Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report......be the first to read our new posts follow us on Twitter at  https://twitter.com/#!/SierraEquity